Skip to main content Accessibility help
×
Hostname: page-component-7c8c6479df-27gpq Total loading time: 0 Render date: 2024-03-29T04:53:29.373Z Has data issue: false hasContentIssue false

29 - Management Commentary

from Section 2 - Management Commentaries

Published online by Cambridge University Press:  17 December 2018

Gordon Parker
Affiliation:
University of New South Wales, Sydney
Get access
Type
Chapter
Information
Bipolar II Disorder
Modelling, Measuring and Managing
, pp. 255 - 262
Publisher: Cambridge University Press
Print publication year: 2019

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Altshuler, L., Kiriakos, L., Calcagno, J. et al. (2001). The impact of antidepressant discontinuation versus antidepressant continuation on 1-year risk for relapse of bipolar depression: a retrospective chart review. Journal Clinical Psychiatry, 62, 612–16.CrossRefGoogle ScholarPubMed
Altshuler, L., Kiriakos, L., Calcagno, J. et al. (2003). Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up. American Journal Psychiatry, 160, 1252–62.Google Scholar
Bauer, M., Berman, S., Stamm, T. et al. (2016). Levothyroxine effects on depressive symptoms and limbic glucose metabolism in bipolar disorder: a randomized, placebo-controlled positron emission tomography study. Molecular Psychiatry, 21, 229–36.CrossRefGoogle ScholarPubMed
Chaudhry, H. R., Khan, R. M., Shabbir, A. et al. (2010). Nimodipine in the treatment of bipolar disorder. Biological Psychiatry, 67, 232S.Google Scholar
Davis, L. L., Bartolucci, A. and Petty, F. et al. (2005). Divalproex in the treatment of bipolar depression: a placebo-controlled study. Journal of Affective Disorders 85, 259–66.Google Scholar
Frye, M. A., Ketter, T. A., Kimbrell, T. A. et al. (2000). A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. Journal of Clinical Psychopharmacology, 20, 607–14.Google Scholar
Geddes, J. R., Gardiner, A., Rendell, J. et al. (2016). Comparative evaluation of quetiapine plus lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in bipolar depression (CEQUEL): a 2 x 2 factorial randomised trial. The Lancet Psychiatry, 3, 31–9.Google Scholar
Ghaemi, S. N., Ostacher, M. M., El-Mallakh, R.S. et al. (2010). Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety. The Journal of Clinical Psychiatry, 71, 372–80.CrossRefGoogle ScholarPubMed
Joffe, R. T., MacQueen, G. M., Marriott, M. et al. (2005). One-year outcome with antidepressant-treatment of bipolar depression. Acta Psychiatrica Scandinavica, 112, 105–9.Google Scholar
Muzina, D. J., Gao, K., Kemp, D. E. et al. (2011). Acute efficacy of divalproex sodium versus placebo in mood stabilizer-naive bipolar I or II depression: a double-blind, randomized, placebo-controlled trial. The Journal of Clinical Psychiatry, 72, 813–19.Google Scholar
Obrocea, G. V., Dunn, R. M., Frye, M. A. et al. (2002). Clinical predictors of response to lamotrigine and gabapentin monotherapy in refractory affective disorders. Biological Psychiatry, 51, 253–60.CrossRefGoogle ScholarPubMed
Post, R. M. (2016a). Epigenetic basis of sensitization to stress, affective episodes, and stimulants: implications for illness progression and prevention. Bipolar Disorders, 18, 315–24.Google Scholar
Post, R. M. (2016b). Treatment of bipolar depression: evolving recommendations. Psychiatric Clinics, 39, 1133.Google Scholar
Post, R. M. (2017a). New perspectives on the course and treatment of bipolar disorder. Minerva Psichiatrica, 58, 4053.Google Scholar
Post, R. M. (2017b). The New News About Lithium: An Underutilized Treatment in The United States, Neuropsychopharmacology, Accepted article preview 4 October 2017; doi: 10.1038/npp.2017.238.Google ScholarPubMed
Post, R. M. (2018). Preventing the malignant transformation of bipolar disorder, JAMA, Published online March 5, 2018. doi:10.1001/jama.2018.0322.Google Scholar
Post, R. M., Altshuler, L. L., Leverich, G. S. et al. (2006). Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline. British Journal of Psychiatry, 189, 124–31.CrossRefGoogle ScholarPubMed
Post, R. M. and Leverich, G. L. (2008). Treatment of bipolar illness: a casebook for clinicians and patients. WW Norton & Company.Google Scholar
Sachs, G. S., Thase, M. E., Otto, M. W. et al. (2003). Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biological Psychiatry, 53, 1028–42.Google Scholar
Terao, T., Ishida, A., Kimura, T. et al. (2017). Preventive effects of lamotrigine in bipolar II versus bipolar I disorder. The Journal of Clinical Psychiatry, 78, e1000–5.CrossRefGoogle ScholarPubMed
Van der Loos, M. L., Mulder, P. G., Hartong, E. G. et al. (2009). Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial. The Journal of Clinical Psychiatry, 70, 223–31.CrossRefGoogle ScholarPubMed
Winsberg, M. E., DeGolia, S. G., Strong, C. M. et al. (2001). Divalproex therapy in medication-naive and mood-stabilizer-naive bipolar II depression. Journal of Affective Disorders, 67, 207–12CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×